• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us

World Markets: Global Insights into Financial Trends and Investment Opportunities

When concerned with the global economy, it’s important to look beyond the powerhouses that are often in the spotlight, and to look at the various emerging markets operating just off stage.

Today’s biggest emerging markets (BEMs), include Argentina, Brazil, China, India, Indonesia, Mexico, Poland, South Africa, South Korea and Turkey. Not as big, but still making impact, are Egypt, Iran, Nigeria, Pakistan, Russia, Saudi Arabia, Taiwan, and Thailand.

These countries are likely to influence the world markets in the short- and long-term. Read on to discover the best ways to profit from the meteoric rise.

World Market News & Analysis

An emerging market economy is an economy that is progressing toward becoming advanced. This can be seen by the level of liquidity in local debt, equity markets, as well as the existence of a market exchange and a regulatory body.

An emerging market has some of the characteristics of a developed market but does not meet enough standards to be classified as one. These include countries that may have been developed markets in the past or are truly in the running to become one in the future.

How do you spot one? Well, they have a few characteristics.

Firstly, they tend to have a lower-than-average per capita income.

The World Bank defines developing countries as those with either lower or lower middle per capita income of less than US$4,035. Low income is the first important criteria because it provides an incentive for the country to pursue the second identifying characteristic — rapid growth.

Rapid social change then leads to the third characteristic — high volatility. This can come from natural disasters, external price shocks, and domestic price instability.

Such traditional economies that are reliant on agriculture are especially vulnerable to natural disasters, such as earthquakes, tsunamis and droughts.

Emerging markets can also get caught in the wind of volatile currency swings, especially those using the dollar. They are also susceptible to market swings in commodities, such as oil or food. Why? It’s because they don’t have enough power to control or influence these movements.

But if they are successful, rapid growth in an emerging market can also lead to the final, and most exciting characteristic — a higher than average return for investors.

Many developing countries focus on an export-driven strategy. Such a demand isn’t a priority back home, so they produce lower-cost consumer goods to deliver to the developed world.

The companies that fuel this growth profit the most, equalling in higher stock prices for their investors, and a higher return on bonds to cover the additional risk of emerging market companies.

You can see, then, why emerging markets are so attractive to investors.

But be warned — not all emerging markets are good investments.

When doing your research, you need to pick your investments carefully.

When looking at emerging markets, you should only pick markets that have little debt and a growing labour market.

Want to know more? Well, read on. At Fat Tail Daily, we provide you with all the latest news and insights into this area, to keep you well informed and in front of the masses.

ASX:NCM ticker

Newcrest Pays Out the Last Golden Goose Before Potential Takeover

By Fat Tail Daily, Friday, 11 August 2023

Newcrest posted mixed results in its latest earnings report but offered a silver lining of a substantial dividend payout that kept the share price fairly steady before the upcoming vote to accept Newmont’s $26.2 billion bid.

ASX NCK Share Price - Nick Scali ASX Shares

Nick Scali [ASX:NCK] Shares Jump After Record Profits

By Charlie Ormond, Friday, 11 August 2023

Furniture company Nick Scali saw its shares surge by 14.5%, trading at $12.25 per share this afternoon as it surprised shareholders with record profits amid slowing consumer spending and high interest rates.

ASX:BLD ticker

Boral [ASX:BLD] Shares Up 8.1% after Beating Profit Expectations

By Charlie Ormond, Thursday, 10 August 2023

Construction materials giant Boral posted strong earnings today, beating expectations as its price increases across the board translated into healthy books. Shares were up by 8.12% this afternoon.

[ASX:TNC] ticker

True North Copper [ASX:TNC] Shares Up 25% After Great First Drill Results

By Fat Tail Daily, Thursday, 10 August 2023

True North Copper has released the results of its inaugural drilling program at its newly purchased Mt Oxide Project in QLD. Its first drill hole saw impressive results of 66.5m at 4.95% Cu.

AGL [ASX:AGL] Energy Posts $1.26 Billion Loss

By Charlie Ormond, Thursday, 10 August 2023

AGL Energy has fallen to an annual loss of $1.26 billion as the energy giant begins to wind down its coal power plants. Underlying profits showed signs of health, thanks to higher wholesale energy prices.

Vaccine for coronavirus infection - covid 19 and syringe for inj

Revealed Under Oath: The Facts and Lies of Vaccine Safety and Efficacy

By Brian Chu, Thursday, 10 August 2023

Almost two months ago, I wrote an article about how Australia was about to get the red pill. Things are now accelerating. Last Thursday, the Senate held an inquiry into vaccine mandates and their impact on the Australian population. Pfizer, Moderna and the TGA faced two hours of questions revealing startling bombshells that showed their negligence and callousness. If you’re of the belief that the medical community and pharmaceutical companies have your best interest in mind, this hearing should shatter it…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Interim pages omitted …
  • Page 618
  • Go to Next Page »

Primary Sidebar

Market Analysis Categories

  • Market Analysis
  • Latest ASX News
  • Dividend Shares
  • Exchange Traded Funds
  • Stocks and Bonds

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988